Stereotactic radiosurgery as the first-line treatment for intracanalicular vestibular schwannomas

View More View Less
  • 1 Departments of Neurological Surgery and
  • 2 Radiation Oncology, and
  • 3 Center for Image-Guided Neurosurgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; and
  • 4 Department of Neurological Surgery, Nihon University School of Medicine, Tokyo, Japan
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

OBJECTIVE

This report evaluates the outcomes of stereotactic radiosurgery (SRS) as the first-line treatment of intracanalicular vestibular schwannomas (VSs).

METHODS

Between 1987 and 2017, the authors identified 209 patients who underwent SRS as the primary intervention for a unilateral intracanalicular VS. The median patient age was 54 years (range 22–85 years); 94 patients were male and 115 were female. Three patients had facial neuropathy at the time of SRS. One hundred fifty-five patients (74%) had serviceable hearing (Gardner-Robertson [GR] grades I and II) at the time of SRS. The median tumor volume was 0.17 cm3 (range 0.015–0.63 cm3). The median margin dose was 12.5 Gy (range 11.0–25.0 Gy). The median maximum dose was 24.0 Gy (range 15.7–50.0 Gy).

RESULTS

The progression-free survival rates of all patients with intracanalicular VS were 97.5% at 3 years, 95.6% at 5 years, and 92.1% at 10 years. The rates of freedom from the need for any additional intervention were 99.4% at 3 years, 98.3% at 5 years, and 98.3% at 10 years. The serviceable hearing preservation rates in GR grade I and II patients at the time of SRS were 76.6% at 3 years, 63.5% at 5 years, and 27.3% at 10 years. In univariate analysis, younger age (< 55 years, p = 0.011), better initial hearing (GR grade I, p < 0.001), and smaller tumor volumes (< 0.14 cm3, p = 0.016) were significantly associated with improved hearing preservation. In multivariate analysis, better hearing (GR grade I, p = 0.001, HR 2.869, 95% CI 1.569–5.248) and smaller tumor volumes (< 0.14 cm3, p = 0.033, HR 2.071, 95% CI 1.059–4.047) at the time of SRS were significantly associated with improved hearing preservation. The hearing preservation rates of patients with GR grade I VS were 88.1% at 3 years, 77.9% at 5 years, and 38.1% at 10 years. The hearing preservation rates of patients with VSs smaller than 0.14 cm3 were 85.5% at 3 years, 77.7% at 5 years, and 42.6% at 10 years. Facial neuropathy developed in 1.4% from 6 to 156 months after SRS.

CONCLUSIONS

SRS provided sustained tumor control in more than 90% of patients with intracanalicular VS at 10 years and freedom from the need for additional intervention in more than 98% at 10 years. Patients with initially better hearing and smaller VSs had enhanced serviceable hearing preservation during an observation interval up to 10 years after SRS.

ABBREVIATIONS ATFS = additional treatment–free survival; GR = Gardner-Robertson; HB = House-Brackmann; PFS = progression-free survival; PTA = pure tone average; SDS = speech discrimination score; SRS = stereotactic radiosurgery; VS = vestibular schwannoma.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Correspondence Hideyuki Kano: University of Pittsburgh School of Medicine, Pittsburgh, PA. kanoh@upmc.edu.

INCLUDE WHEN CITING Published online February 5, 2021; DOI: 10.3171/2020.9.JNS202818.

Disclosures Dr. Lunsford reports being a consultant for the Insightec Data and Safety Monitoring Board and an Elekta AB stockholder.

  • 1

    Matthies C, Samii M. Management of 1000 vestibular schwannomas (acoustic neuromas): clinical presentation. Neurosurgery. 1997;40(1):110.

    • Search Google Scholar
    • Export Citation
  • 2

    Sughrue ME, Yang I, Aranda D, The natural history of untreated sporadic vestibular schwannomas: a comprehensive review of hearing outcomes. J Neurosurg. 2010;112(1):163167.

    • Search Google Scholar
    • Export Citation
  • 3

    Koos WT, Day JD, Matula C, Levy DI. Neurotopographic considerations in the microsurgical treatment of small acoustic neurinomas. J Neurosurg. 1998;88(3):506512.

    • Search Google Scholar
    • Export Citation
  • 4

    Niranjan A, Mathieu D, Flickinger JC, Hearing preservation after intracanalicular vestibular schwannoma radiosurgery. Neurosurgery. 2008;63(6):10541063.

    • Search Google Scholar
    • Export Citation
  • 5

    House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg. 1985;93(2):146147.

  • 6

    Gardner G, Robertson JH. Hearing preservation in unilateral acoustic neuroma surgery. Ann Otol Rhinol Laryngol. 1988;97(1):5566.

  • 7

    Régis J, Carron R, Park MC, Wait-and-see strategy compared with proactive Gamma Knife surgery in patients with intracanalicular vestibular schwannomas. J Neurosurg. 2010;113(suppl):105111.

    • Search Google Scholar
    • Export Citation
  • 8

    Akpinar B, Mousavi SH, McDowell MM, Early radiosurgery improves hearing preservation in vestibular schwannoma patients with normal hearing at the time of diagnosis. Int J Radiat Oncol Biol Phys. 2016;95(2):729734.

    • Search Google Scholar
    • Export Citation
  • 9

    Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3(1):3235.

  • 10

    Kano H, Kondziolka D, Khan A, Predictors of hearing preservation after stereotactic radiosurgery for acoustic neuroma. J Neurosurg. 2009;111(4):863873.

    • Search Google Scholar
    • Export Citation
  • 11

    Goldbrunner R, Weller M, Regis J, EANO guideline on the diagnosis and treatment of vestibular schwannoma. Neuro Oncol. 2020;22(1):3145.

    • Search Google Scholar
    • Export Citation
  • 12

    Kondziolka D, Mousavi SH, Kano H, The newly diagnosed vestibular schwannoma: radiosurgery, resection, or observation? Neurosurg Focus. 2012;33(3):E8.

    • Search Google Scholar
    • Export Citation
  • 13

    Kaul V, Cosetti MK. Management of vestibular schwannoma (including NF2): facial nerve considerations. Otolaryngol Clin North Am. 2018;51(6):11931212.

    • Search Google Scholar
    • Export Citation
  • 14

    Dzierzęcki S, Turek G, Czapski B, Gamma knife surgery in the treatment of intracanalicular vestibular schwannomas. Acta Neurol Scand. 2020;141(5):415422.

    • Search Google Scholar
    • Export Citation
  • 15

    Johnson S, Kano H, Faramand A, Predicting hearing outcomes before primary radiosurgery for vestibular schwannomas. J Neurosurg. 2020;133(4):12351241.

    • Search Google Scholar
    • Export Citation
  • 16

    Tamura M, Carron R, Yomo S, Hearing preservation after gamma knife radiosurgery for vestibular schwannomas presenting with high-level hearing. Neurosurgery. 2009;64(2):289296.

    • Search Google Scholar
    • Export Citation
  • 17

    Lees KA, Tombers NM, Link MJ, Natural history of sporadic vestibular schwannoma: a volumetric study of tumor growth. Otolaryngol Head Neck Surg. 2018;159(3):535542.

    • Search Google Scholar
    • Export Citation
  • 18

    Flickinger JC, Kano H, Niranjan A, Dose selection in stereotactic radiosurgery. Prog Neurol Surg. 2013;27:4957.

  • 19

    Flickinger JC, Kondziolka D, Niranjan A, Acoustic neuroma radiosurgery with marginal tumor doses of 12 to 13 Gy. Int J Radiat Oncol Biol Phys. 2004;60(1):225230.

    • Search Google Scholar
    • Export Citation
  • 20

    Niranjan A, Lunsford LD, Flickinger JC, Dose reduction improves hearing preservation rates after intracanalicular acoustic tumor radiosurgery. Neurosurgery. 1999;45(4):753765.

    • Search Google Scholar
    • Export Citation
  • 21

    Johnson S, Kano H, Faramand A, Long term results of primary radiosurgery for vestibular schwannomas. J Neurooncol. 2019;145(2):247255.

    • Search Google Scholar
    • Export Citation
  • 22

    Watanabe S, Yamamoto M, Kawabe T, Stereotactic radiosurgery for vestibular schwannomas: average 10-year follow-up results focusing on long-term hearing preservation. J Neurosurg. 2016;125(suppl 1):6472.

    • Search Google Scholar
    • Export Citation
  • 23

    Hasegawa T, Kida Y, Kato T, Long-term safety and efficacy of stereotactic radiosurgery for vestibular schwannomas: evaluation of 440 patients more than 10 years after treatment with Gamma Knife surgery. J Neurosurg. 2013;118(3):557565.

    • Search Google Scholar
    • Export Citation
  • 24

    Wolf A, Naylor K, Tam M, Risk of radiation-associated intracranial malignancy after stereotactic radiosurgery: a retrospective, multicentre, cohort study. Lancet Oncol. 2019;20(1):159164.

    • Search Google Scholar
    • Export Citation
  • 25

    Patel TR, Chiang VLS. Secondary neoplasms after stereotactic radiosurgery. World Neurosurg. 2014;81(3-4):594599.

  • 26

    Schwartz MS, Lekovic GP, Miller ME, Translabyrinthine microsurgical resection of small vestibular schwannomas. J Neurosurg. 2018;129(1):128136.

    • Search Google Scholar
    • Export Citation
  • 27

    Zhu W, Chen H, Jia H, Long-term hearing preservation outcomes for small vestibular schwannomas: retrosigmoid removal versus observation. Otol Neurotol. 2018;39(2):e158e165.

    • Search Google Scholar
    • Export Citation
  • 28

    Yamakami I, Ito S, Higuchi Y. Retrosigmoid removal of small acoustic neuroma: curative tumor removal with preservation of function. J Neurosurg. 2014;121(3):554563.

    • Search Google Scholar
    • Export Citation
  • 29

    Nakatomi H, Jacob JT, Carlson ML, Long-term risk of recurrence and regrowth after gross-total and subtotal resection of sporadic vestibular schwannoma. J Neurosurg. 2020;133(4):10521058.

    • Search Google Scholar
    • Export Citation
  • 30

    Noudel R, Gomis P, Duntze J, Hearing preservation and facial nerve function after microsurgery for intracanalicular vestibular schwannomas: comparison of middle fossa and retrosigmoid approaches. Acta Neurochir (Wien). 2009;151(8):935945.

    • Search Google Scholar
    • Export Citation
  • 31

    Colletti V, Fiorino F. Is the middle fossa approach the treatment of choice for intracanalicular vestibular schwannoma? Otolaryngol Head Neck Surg. 2005;132(3):459466.

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 608 608 608
Full Text Views 96 96 96
PDF Downloads 49 49 49
EPUB Downloads 0 0 0